Table 1.
Primer | Sequence (5′–3′) | Accession no. | Product size (bp) |
---|---|---|---|
MC2R forward | CACCATCTTCCACGCACTGC | ||
MC2R reverse | CCTGGTGTGGGATCGAGCC | 225 | |
5′-RACE | AGCCAGCAGGAACATGTGGACGTA | 649 | |
3′-RACE | TCCACGCCCTGCGCTACCAC | ||
3′-Nested | CGGGGATCTGGGCGCTATGC | 836 | |
Full MC2R forward | TGTGGACGTTGCTCTGACAC | ||
Full MC2R reverse | GGGTCAAAAACTCTGGTGGA | ||
MC2R forward (qPCR) | GAGAACCTGTTGGTGGTGGT | EU119870 | 105 |
MC2R reverse (qPCR) | GAGGGAGGAGATGGTGTTGA | ||
StAR forward | TGGGGAAGGTGTTTAAGCTG | AB047032 | 101 |
StAR reverse | AGGGTTCCAGTCTCCCATCT | ||
P450scc forward | GCTTCATCCAGTTGCAGTCA | S57305.1 | 140 |
P450scc reverse | CAGGTCTGGGGAACACATCT | ||
β-Actin forward | TGTCCCTGTATGCCTCTGGT | AF157514 | 121 |
β-Actin reverse | AAGTCCAGACGGAGGATGG |